Therapeutic Solutions International Provides Correction Re Prior Release
Therapeutic Solutions International announced today the correction of a statement made in a press release dated March 25, 2022, that said, among other things, that: As part of the trial organization, the Principal Investigator has been changed to Dr. James Veltmeyer and Therapeutic Solutions International, Inc as the Sponsor.
- Therapeutic Solutions International announced today the correction of a statement made in a press release dated March 25, 2022, that said, among other things, that: As part of the trial organization, the Principal Investigator has been changed to Dr. James Veltmeyer and Therapeutic Solutions International, Inc as the Sponsor.
- In addition to clarify, JadiCell adult stem cells are umbilical cord derived mesenchymal like stromal cells also referred to as adult stem cells.1-5
Therapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases. - Slavin S, Kurkalli BG, Karussis D: The potential use of adult stem cells for the treatment of multiple sclerosis and other neurodegenerative disorders.
- Hafizi, M., et al., Exploring the enkephalinergic differentiation potential in adult stem cells for cell therapy and drug screening implications.